Back to search

United Kingdom· GB-APID-328411000001100

Otrivine Antistin 0.5%/0.05% eye drops

A medicinal product containing antazoline + xylometazoline, registered in United Kingdom by Thea Pharmaceuticals Ltd.

Checked against NHS dm+d (United Kingdom) on

Informational only — not a medical device.

SOURCE REGISTER · GBNHS dm+d (United Kingdom)normalisedOtrivine Antistin 0.5%/0.05% eye dropsATC—REGISTER NO.GB-APID-3284110000011…PACKS LISTED1CHECKEDOctober 2, 2026

The record

At a glance

NHS dm+d (United Kingdom)
Active substance
Antazoline + Xylometazoline
Manufacturer
Thea Pharmaceuticals Ltd
Country
United Kingdom (GB)
ATC code
—
Reimbursed
Not published by this register
Source register
NHS dm+d (United Kingdom)
Last checked
October 2, 2026

Packs & prices · 1

  • gtin
    0000050487172

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/a3a0bd93-5fa2-4aa7-bfe8-a92c7add195e
GET /v1/drugs/a3a0bd93-5fa2-4aa7-bfe8-a92c7add195e?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "apid": "328411000001100",
  "desc": "Otrivine Antistin 0.5%/0.05% eye drops (Thea Pharmaceuticals Ltd)",
  "form": "Eye drops",
  "vpid": "42184311000001101",
  "source": "dmd",
  "vtm_id": "774616007",
  "strength": "5 mg",
  "substance": "Antazoline + Xylometazoline",
  "ingredient": "Antazoline sulfate",
  "supplier_code": "14937811000001101"
}

See everything about antazoline + xylometazoline.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.